It specifically binds to TNF-alpha and inhibits the interaction of tumor necrosis factor (TNF) with surface TNF receptors, thereby reducing clinical symptoms along with ceasing disease progression in patients with RA [12–14]. This evidence concerns the gene TNF and rheumatoid arthritis.